Supplementation with L. acidophilus significantly reduced the hepatic steatosis and injury by upregulating the bile acid receptor FXR/fibroblast growth factor 15 (FGF15) signaling, suggesting the potential of probiotic bacteria to mitigate NAFLD through the regulation of bile acid metabolism [162]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.